addenda and errata
Rv0100, a proposed acyl Mycobacterium tuberculosis: expression, purification and crystallization. Corrigendum
inaInstitute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA, bOncobiologics Inc., 7 Clarke Drive, Cranbury, NJ 08512, USA, cDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 12371, Saudi Arabia, dVaccines and Biologics Research Unit, College of Pharmacy, King Saud University, Riyadh 12371, Saudi Arabia, eDepartment of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA, fDepartment of Psychiatry, University of Illinois at Chicago, 1601 West Taylor Street, Room 425, Chicago, IL 60612, USA, gHollingbery and Son Hops Inc., 302 North First Avenue, Yakima, WA 98907, USA, hDepartment of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, State University of New York (SUNY), University at Buffalo, 77 Goodell Street, Buffalo, NY 14203, USA, iNovaScan Inc., 950 N. 12th Street, Milwaukee,, WI 53233, USA, jDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA, kStructural Biology Center, Advanced Photon Source, Argonne National Laboratory, 9700 S Cass Ave, Lemont, IL 60439, USA, and lCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA
*Correspondence e-mail: shahila@gmail.com, movahed@uic.edu
The true identity of the protein found in the crystals reported by Bondoc et al. [(2019), Acta Cryst. F75, 646–651] is given.
Keywords: acyl carrier protein; Mycobacterium tuberculosis; Mycobacterium smegmatis; Rv0100; corrigendum.
As described in the article by Bondoc et al. (2019), attempts to solve the (2 monomers per a.u. in the H3 cell), using existing structural homologs of Rv0100 Mycobacterium tuberculosis from the Protein Data Bank failed. Structural models obtained from the amino-acid sequence using the I-THASSER protein prediction server also failed. of tentative solutions obtained by MOLREP and PHASER stalled at Rw = 0.44, Rf = 0.51, even when assuming a lower symmetry P1 lattice with nearly H3 pseudo-symmetry. Detailed examination of the PDB entries related to proteins from Mycobacterium smegmatis, the organism that was used as an expression strain, revealed the existence of entry 3gwm corresponding to the of the holo-[acyl-carrier-protein] synthase (ACPS). This structure was released in 2010 (Poulsen, C., Wilmanns, M. & Song, Y. H., unpublished work). The crystallographic parameters for this deposition (space group H3, a = 67.45, b = 67.45, c = 86.06 Å, α = β = 90, γ = 120°) strongly suggested that it was the same protein as the one we had crystallized. Using the protein structure from entry 3gwm, a solution was readily found and was further refined to Rw = 0.19, Rf = 0.25 following standard protocols using the previously reported crystallographic data to 2.0 Å resolution. The amino-acid sequence of the refined protein was fully consistent with the sequence in the ACPS entry, and significant structural differences were found only in the proximity of the three SO4 anions bound in 3gwm but not in the serendipitously found structure, since there was no sulfate in our crystallization media. The r.m.s.d. between 128 equivalent Cα carbons in the two structures was 0.58 Å (mean deviation 0.33 Å).
We hypothesize that our expression in the M. smegmatis strain resulted in the co-purification of ACPS protein from M. smegmatis, as a minor contaminant. This is consistent with the fact that only two very small (10–20 µm) crystals were observed in the crystallization droplet and it took about nine months for these crystals to appear. We are certain that the predominant purified protein is Rv0100 from M. tuberculosis confirmed through both and the fact that the histidine tag was used to isolate the protein. We are confident that the ACPS protein (MW ≃ 14 000 Da) was a minor contaminant that co-purified alongside Rv0100 whose molecular weight is significantly different (11 122 Da).
Funding information
The following funding is acknowledged: American Lung Association (grant No. RG-82534-N).
References
Bondoc, J. M. G., Gutka, H. J., Almutairi, M. M., Patwell, R., Rutter, M. W., Wolf, N. M., Samudrala, R., Mehboob, S. & Movahedzadeh, F. (2019). Acta Cryst. F75, 646–651. CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.